| Tiffany Moore Bourgeois, MD | |
|
8212 Summa Ave, Baton Rouge, LA 70809-3421 | |
| (225) 769-4403 | |
| (225) 769-3842 |
| Full Name | Tiffany Moore Bourgeois |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 17 Years |
| Location | 8212 Summa Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063602431 | NPI | - | NPPES |
| 1000892 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD.202681 (Louisiana) | Primary |
| 207L00000X | Anesthesiology | 2011-00769 (North Carolina) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiology Group Associates Inc | 0042110298 | 151 |
| Louisiana Anesthesiology Group L.l.c. | 6507758505 | 29 |
News Archive
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments.
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
› Verified 1 days ago
| Entity Name | Anesthesiology Group Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments.
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
› Verified 1 days ago
| Entity Name | Louisiana Anesthesiology Group L.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902957103 PECOS PAC ID: 6507758505 Enrollment ID: O20040325001171 |
News Archive
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments.
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Moore Bourgeois, MD 2012 Pointe South Dr, Zachary, LA 70791-5426 Ph: (225) 202-0946 | Tiffany Moore Bourgeois, MD 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 |
News Archive
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.
The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).
As cancer researchers continue to identify genetic mutations driving different cancer subtypes, they are also creating a catalog of possible targets for new treatments.
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
› Verified 1 days ago
Sara Adams Martin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 Fax: 225-214-6437 | |
James C Bagot, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Womans Way, Baton Rouge, LA 70817 Phone: 225-293-2523 Fax: 255-293-1807 | |
Dr. Roger Hector, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 10620 Timberlake Ave, Baton Rouge, LA 70810 Phone: 225-761-1981 Fax: 225-761-1983 | |
Dr. Leslie Kay Sheffield, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11408 Lake Sherwood Ave N Ste A, Baton Rouge, LA 70816 Phone: 225-754-9478 Fax: 225-659-8033 | |
Charles V Benedetto, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Dr. Robert James Schutte, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11408 Lake Sherwood Ave N Ste A, Baton Rouge, LA 70816 Phone: 225-754-9478 Fax: 225-659-8033 |